Search, Find and Buy Antibodies, ELISA Kits and Proteins.
Loading Loading
Order hotline:
phone +1 404 474 4654
fax +1 888 205 9894 (TF)
Details for Product No. ABIN350656

Oligodendrocyte Lineage Transcription Factor 2 (OLIG2) (N-Term) antibody

Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Synonyms BHLHB1, OLIGO2, RACK17, PRKCBP2, bHLHe19, AI604895, Bhlhb1, Olg-2, Oligo2, RK17, wu:fc64g09, olig3.2, MGC89336, OLIG2
»Alternatives N-Term
»Alternatives Human, Rat (Rattus), Mouse (Murine)
»Alternatives Rabbit
Clonality Polyclonal
»Alternatives Un-conjugated
»Alternatives Immunohistochemistry (IHC), Western Blotting (WB), Flow Cytometry (FACS)
Pubmed 4 references available
Catalog no. ABIN350656
Quantity 100 µL
454.67 $   Plus shipping costs $45.00
Shipping to
Availability Will be delivered in 7 to 8 Business Days
Immunogen A synthetic peptide from the n-terminal region of human OLIG2 conjugated to an immunogenic carrier protein was used as the antigen. The peptide is homologous in rat and mouse.
Specificity Specific for P2RY5.
Purification Purified mouse LN T cells
Purity whole serum
Alternative Name OLIG2 (Oligo2, bHLHB1, RACK17)
Background Function: Required for oligodendrocyte and motor neuron specification in the spinal cord, as well as for the development of somatic motor neurons in the hindbrain. Cooperates with OLIG1 to establish the pMN domain of the embryonic neural tube. Antagonist of V2 interneuron and of NKX2-2-induced V3 interneuron development.
Subcellular location: Nucleus. Cytoplasm
Tissue specificity: Expressed in the brain, in oligodendrocytes. Strongly expressed in oligodendrogliomas, while expression is weak to moderate in astrocytomas. Expression in glioblastomas highly variable. Involvement in disease: A chromosomal aberration involving OLIG2 may be a cause of a form of T-cell acute lymphoblastic leukemia (T-ALL). Translocation t(14,21)(q11.2,q22) with TCRA. Also known as: Basic helix loop helix protein class B 1, BHLHB1, olig2, OLIGO2, Oligodendrocyte specific bHLH transcription factor 2, Oligodendrocyte transcription factor 2, PRKCBP2, Protein kinase C binding protein 2, Protein kinase C binding protein RACK17, RACK17.
UniProt Q8BMC0
Application Notes A dilution of 1 : 300 to 1 : 2000 is recommended.
The optimal dilution should be determined by the end user.
Not yet tested in other applications.
Restrictions For Research Use only
Format Lyophilized
Reconstitution Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handling Advice Avoid freeze and thaw cycles.
Storage -20 °C
Storage Comment Maintain the lyophilised/reconstituted antibodies frozen at -20 °C for long term storage and refrigerated at 2-8 °C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability.
Expiry Date 12 months
Wang, Jani-Sait, Escalon et al.: "The t(14;21)(q11.2;q22) chromosomal translocation associated with T-cell acute lymphoblastic leukemia activates the BHLHB1 gene." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, Issue 7, pp. 3497-502, 2000 (PubMed).

Marie, Sanson, Mokhtari et al.: "OLIG2 as a specific marker of oligodendroglial tumour cells." in: Lancet, Vol. 358, Issue 9278, pp. 298-300, 2001 (PubMed).

Lu, Park, Noll et al.: "Oligodendrocyte lineage genes (OLIG) as molecular markers for human glial brain tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 19, pp. 10851-6, 2001 (PubMed).

Ota, Suzuki, Nishikawa et al.: "Complete sequencing and characterization of 21,243 full-length human cDNAs." in: Nature genetics, Vol. 36, Issue 1, pp. 40-5, 2003 (PubMed).

Alternatives for antigen "Oligodendrocyte Lineage Transcription Factor 2 (OLIG2)", type "Antibodies"
Hosts (67), (12), (2), (2)
Reactivities (75), (42), (38), (14), (13), (12), (12), (1), (1)
Applications (70), (34), (31), (15), (12), (10), (8), (7), (7), (3), (1)
Conjugates (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Epitopes (13), (8), (6), (3), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1)